Status | Study |
NOT_YET_RECRUITING |
Study Name: Effects of Oral Supplement Containing L-Histidine and Antioxidants on the Skin Barrier Function and Systemic Inflammation in Rosacea Condition: Rosacea Date: 2023-10-02 Interventions: Supplment powder |
Not yet recruiting |
Study Name: Intense Pulsed Light as an Adjunctive to Bromonidine for the Treatment of Rosacea Condition: Rosacea Date: 2017-02-06 Interventions: Drug: Bromonide 0.33% gel Pati |
Recruiting |
Study Name: DMT210 Topical Gel in the Treatment of Acne Rosacea Condition: Acne Rosacea Date: 2016-12-20 Interventions: Drug: DMT210 Topical Gel 5% Other: Vehicle |
Completed |
Study Name: A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea Condition: Rosacea Date: 2014-04-21 Interventions: Drug: Azelaic acid Dosage form: Topical gel Dosage: Apply gel to the affected areas of the face twice da |
Completed |
Study Name: A 21 Day Pharmacokinetics Study in Papulopustular Rosacea Condition: Papulopustular Rosacea Date: 2013-11-27 Interventions: Drug: CLS001 |
Completed |
Study Name: A Twelve Week Safety and Efficacy Study in Rosacea Condition: Papulopustular Rosacea Date: 2013-02-01 Interventions: Drug: omiganan Drug: placebo |
Completed |
Study Name: Azelaic Acid on Demodex Counts in Rosacea Condition: Rosacea Date: 2012-12-19 Interventions: Drug: Azelaic acid 15% gel twice daily for four weeks to one side of face |
Completed |
Study Name: Combination Gel and Vascular ND in Mild to Moderate Rosacea Condition: Rosacea Date: 2012-06-27 Interventions: Drug: Azelaic acid 15% gel, tw |
Completed |
Study Name: A Double-Blinded, Randomized Placebo Controlled Pilot Study Comparing the Efficacy and Safety of IncobotulinumtoxinA Versus Saline Injections to the Cheek Region in Patients With Rosacea Condition: Rosacea Date: 2012-06-04 Interventions: Drug: IncobotulinumtoxinA Expe |
Completed |
Study Name: Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea Condition: Papulopustular Rosacea Date: 2012-03-13 Interventions: Drug: Azelaic acid foam, 15% (BAY39-6251) |